相关实验视频

Updated: Sep 16, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

虚拟选,优化设计和合成分析新型松衍生物作为泛基因型HCV NS5B聚合酶抑制剂,使用分子建模

Di Han1,2,3, Yiwei Xue4,5,6, Fang Zhao4,5,6

  • 1School of Medical Engineering, Xinxiang Medical University, Xinxiang, Henan, 453003, China. hd@xxmu.edu.cn.

BMC chemistry
|July 4, 2025
PubMed
概括

研究人员开发了针对型肝炎病毒 (HCV) NS5B聚合酶的新型福化合物. 这些泛基因型抑制剂显示出稳定的结合性和有希望的药物动力学特征,用于有效的HCV治疗.

关键词:
药物设计 药物设计在HCV NS5B聚合酶.分子动力学模拟的模拟.全基因型的佐原抑制剂反向合成分析的分析.

更多相关视频

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.0K
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.8K

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K